NASDAQ: IMUX
Immunic Inc Stock Ownership - Who owns Immunic?

Insider buying vs selling

Have Immunic Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Duane NashExecutive Chairman2025-06-1320,000$0.84
$16.70kBuy
Joerg NeermannDirector2025-06-0530,000$0.76
$22.80kBuy
Jason TardioPresident and COO2025-06-0512,512$0.79
$9.88kBuy
Jason TardioPresident and COO2025-06-0512,512$0.79
$9.88kBuy
Daniel VittCEO and Director2025-06-0415,000$0.77
$11.55kBuy
Joerg NeermannDirector2025-06-0470,000$0.77
$53.90kBuy
Daniel VittCEO and Director2025-06-0415,000$0.77
$11.55kBuy
Richard Alan RudickDirector2025-06-03143,075$0.70
$100.01kBuy
Glenn WhaleyChief Financial Officer2025-06-0345,000$0.71
$32.09kBuy
Glenn WhaleyChief Financial Officer2025-05-3025,000$0.56
$14.00kBuy

1 of 2

IMUX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMUX insiders and whales buy or sell their stock.

IMUX Shareholders

What type of owners hold Immunic Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aberdeen Group PLC8.60%8,243,941$6.60MInstitution
Bvf Inc7.99%7,652,972$6.12MInstitution
Soleus Capital Management LP7.61%7,293,007$5.83MInstitution
Muneer A. Satter7.44%7,132,277$5.71MInsider
Avidity Partners Management LP5.86%5,615,811$4.49MInstitution
Vanguard Group Inc4.31%4,125,148$3.30MInstitution
Morgan Stanley3.79%3,628,528$2.90MInstitution
Focus Partners Wealth2.65%2,542,524$2.03MInstitution
V. Cooperatieve Ua Lsp2.26%2,162,782$1.73MInsider
Laurion Capital Management LP1.99%1,905,063$1.52MInstitution

1 of 3

IMUX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMUX52.37%16.57%Net Buying
DTIL13.92%86.08%Net SellingNet Buying
XBIT11.20%46.67%
RPTX54.39%45.61%Net Selling
COEP0.33%99.67%

Immunic Stock Ownership FAQ

Who owns Immunic?

Immunic (NASDAQ: IMUX) is owned by 52.37% institutional shareholders, 16.57% Immunic insiders, and 31.06% retail investors. Muneer A. Satter is the largest individual Immunic shareholder, owning 7.13M shares representing 7.44% of the company. Muneer A. Satter's Immunic shares are currently valued at $5.71M.

If you're new to stock investing, here's how to buy Immunic stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.